Author:
Bryan R T,Regan H L,Pirrie S J,Devall A J,Cheng K K,Zeegers M P,James N D,Knowles M A,Ward D G
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Adamczyk K, Tehrani M, Warnken U, Schmiegel W, Schnölzer M, Schwarte-Waldhoff I (2011) Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci 89: 304–312.
2. Babjuk M, Burger M, Zigeuner R, Shariat S, van Rhijn B, Compérat E, Sylvester R, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64: 639–653.
3. Baron A, Cora E, Lafky J, Boardman C, Buenafe M, Rademaker A, Liu D, Fishman D, Podratz K, Maihle N (2003) Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12: 103–113.
4. Bryan R, Kirby R, O'Brien T, Mostafid H (2014a) So much cost, such little progress. Eur Urol 66: 253–262.
5. Bryan R, Shimwell N, Wei W, Devall A, Pirrie S, James N, Zeegers M, Cheng K, Martin A, Ward D (2014b) Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential. Br J Cancer 110: 679–685.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献